IMMVF OTC
Immunovia AB
1W: +0.0%
1M: -50.0%
3M: -50.0%
YTD: -50.0%
1Y: -80.8%
3Y: -99.1%
5Y: -99.8%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$3.1M
52W Range0.01-0.15
Volume325
Avg Volume271
Beta2.65
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJeff Borcherding
Employees13
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2019-06-28
Websiteimmunovia.com
Medicon Village
Lund, SN 223 63
SE
Lund, SN 223 63
SE
46 4 62 75 60 00
About Immunovia AB
Immunovia AB engages in the development of methods for diagnosing complex forms of cancer and autoimmune diseases. Its technology platform, IMMray, focuses on the early diagnosis of cancer, predicts disease progression, and monitors therapeutic responsiveness of cancers. The company was founded by Karl Arne Krister Borrebaeck on May 24, 2007 and is headquartered in Lund, Sweden.
Recent Insider Trades
No insider trades found